2017-2025 World Adalimumab Biosimilar Market Research Report (by Product Type, End-User / Application and Regions / Countries)

Publisher Name :
Date: 22-Oct-2019
No. of pages: 108

Summary

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.

The report includes an in-depth analysis of the Global market for Adalimumab Biosimilar , covering Global total and major region markets.

The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).

The report provides introduction of leading Global manufacturers.

Adalimumab Biosimilar market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries

- North America (U.S., Canada, Mexico)

- Europe (Germany, U.K., France, Italy, Russia, Spain etc)

- Asia-Pacific (China, India, Japan, Southeast Asia etc)

- South America (Brazil, Argentina etc)

- Middle East & Africa (Saudi Arabia, South Africa etc)

By Type

- Tablet

- Oral Solution

By End-User / Application

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

By Company

- AET BioTech

- Amgen

- Boehringer Ingelheim

- Coherus Biosciences

- Fujifilm Kyowa Kirin Biologics

- LG Life Sciences/Mochida Pharmaceutical

- Momenta Pharmaceuticals

- Oncobiologics

- Pfizer

- Samsung Bioepsis

- Sandoz

- Zydus Cadila

2017-2025 World Adalimumab Biosimilar Market Research Report (by Product Type, End-User / Application and Regions / Countries)

Table of Contents

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 North America Market
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 Europe Market
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 Asia-Pacific Market
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 South America Market
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 Middle East & Africa Market
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.Colgate AET BioTech
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Amgen
12.3 Boehringer Ingelheim
12.4 Coherus Biosciences
12.5 Fujifilm Kyowa Kirin Biologics
12.6 LG Life Sciences/Mochida Pharmaceutical
12.7 Momenta Pharmaceuticals
12.8 Oncobiologics
12.9 Pfizer
12.10 Samsung Bioepsis
12.11 Sandoz
12.12 Zydus Cadila
13 Price Overview
13.1 Price Segment
13.2 Price Trend
14 Research Conclusion

List of Tables

Table Global Adalimumab Biosimilar Market and Growth by Type
Table Global Adalimumab Biosimilar Market and Growth by End-Use / Application
Table Global Adalimumab Biosimilar Revenue (Million USD) by Vendors (2017-2019)
Table Global Adalimumab Biosimilar Revenue Share by Vendors (2017-2019)
Table Global Adalimumab Biosimilar Market Volume (Volume) by Vendors (2017-2019)
Table Global Adalimumab Biosimilar Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Adalimumab Biosimilar Market (Million USD) by Type (2017-2019)
Table Global Adalimumab Biosimilar Market Share by Type (2017-2019)
Table Global Adalimumab Biosimilar Market Volume (Volume) by Type (2017-2019)
Table Global Adalimumab Biosimilar Market Volume Share by Type (2017-2019)
Table Global Adalimumab Biosimilar Market (Million USD) by End-Use / Application (2017-2019)
Table Global Adalimumab Biosimilar Market Share by End-Use / Application (2017-2019)
Table Global Adalimumab Biosimilar Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Adalimumab Biosimilar Market Volume Share by End-Use / Application (2017-2019)
Table Global Adalimumab Biosimilar Market (Million USD) by Regions (2017-2019)
Table Global Adalimumab Biosimilar Market Share by Regions (2017-2019)
Table Global Adalimumab Biosimilar Market Volume (Volume) by Regions (2017-2019)
Table Global Adalimumab Biosimilar Market Volume Share by Regions (2017-2019)
Table North America Adalimumab Biosimilar Market (Million USD) by Type (2017-2019)
Table North America Adalimumab Biosimilar Market Share by Type (2017-2019)
Table North America Adalimumab Biosimilar Market (Million USD) by End-Use / Application (2017-2019)
Table North America Adalimumab Biosimilar Market Share by End-Use / Application (2017-2019)
Table North America Adalimumab Biosimilar Market (Million USD) by Regions (2017-2019)
Table North America Adalimumab Biosimilar Market Share by Regions (2017-2019)
Table Europe Adalimumab Biosimilar Market (Million USD) by Type (2017-2019)
Table Europe Adalimumab Biosimilar Market Share by Type (2017-2019)
Table Europe Adalimumab Biosimilar Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Adalimumab Biosimilar Market Share by End-Use / Application (2017-2019)
Table Europe Adalimumab Biosimilar Market (Million USD) by Regions (2017-2019)
Table Europe Adalimumab Biosimilar Market Share by Regions (2017-2019)
Table Asia-Pacific Adalimumab Biosimilar Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Adalimumab Biosimilar Market Share by Type (2017-2019)
Table Asia-Pacific Adalimumab Biosimilar Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Adalimumab Biosimilar Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Adalimumab Biosimilar Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Adalimumab Biosimilar Market Share by Regions (2017-2019)
Table South America Adalimumab Biosimilar Market (Million USD) by Type (2017-2019)
Table South America Adalimumab Biosimilar Market Share by Type (2017-2019)
Table South America Adalimumab Biosimilar Market (Million USD) by End-Use / Application (2017-2019)
Table South America Adalimumab Biosimilar Market Share by End-Use / Application (2017-2019)
Table South America Adalimumab Biosimilar Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Adalimumab Biosimilar Market Share by Regions (2017-2019)
Table Middle East & Africa Adalimumab Biosimilar Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Adalimumab Biosimilar Market Share by Type (2017-2019)
Table Middle East & Africa Adalimumab Biosimilar Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Adalimumab Biosimilar Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Adalimumab Biosimilar Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Adalimumab Biosimilar Market Share by Regions (2017-2019)
Table Global Adalimumab Biosimilar Market (Million USD) Forecast by Regions (2020-2025)
Table Global Adalimumab Biosimilar Market Share Forecast by Regions (2020-2025)
Table Global Adalimumab Biosimilar Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Adalimumab Biosimilar Market Volume Share Forecast by Regions (2020-2025)
Table Global Adalimumab Biosimilar Market (Million USD) Forecast by Type (2020-2025)
Table Global Adalimumab BiosimilarMarket Share by Forecast Type (2020-2025)
Table Global Adalimumab Biosimilar Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Adalimumab Biosimilar Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of AET BioTech
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen
Table Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim
Table Sales Revenue, Volume, Price, Cost and Margin of Coherus Biosciences
Table Sales Revenue, Volume, Price, Cost and Margin of Fujifilm Kyowa Kirin Biologics
Table Sales Revenue, Volume, Price, Cost and Margin of LG Life Sciences/Mochida Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Momenta Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Oncobiologics
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Samsung Bioepsis
Table Sales Revenue, Volume, Price, Cost and Margin of Sandoz
Table Sales Revenue, Volume, Price, Cost and Margin of Zydus Cadila

List of Figures

Figure Global Adalimumab Biosimilar Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Adalimumab Biosimilar Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Adalimumab Biosimilar Market Volume (Volume) and Growth Forecast (2020-2025)
  • Global Oncology Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 07-Dec-2019        Price: US 3300 Onwards        Pages: 119
    Summary The report forecast global Oncology Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Oncology Biosimilars industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Oncology Biosimilars by geography. The report splits the market size, by volume an......
  • Global Follow-On-Biologics Market Report 2019, Competitive Landscape, Trends and Opportunities
    Published: 29-Nov-2019        Price: US 2960 Onwards        Pages: 137
    The Follow-On-Biologics market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026. The report mainly studies the size, recent trends and development status of the Follow-On-Biologics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancem......
  • Global Biologics and Biosimilars Market Growth 2019-2024
    Published: 28-Nov-2019        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Biologics and Biosimilars market will register a 4.6% CAGR in terms of revenue, the global market size will reach US$ 256540 million by 2024, from US$ 214000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biologics and Biosimilars business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Biologics......
  • 2017-2025 World Oncology Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 26-Nov-2019        Price: US 2800 Onwards        Pages: 102
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Oncology Biosimilars , covering Global total and......
  • Global Biologics and Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 22-Nov-2019        Price: US 3300 Onwards        Pages: 166
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global Adalimumab Biosimilar Market Professional Survey Report 2019
    Published: 20-Nov-2019        Price: US 3500 Onwards        Pages: 114
    The global Adalimumab Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Adalimumab Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adalimumab Biosimilar market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent co......
  • Global Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 20-Nov-2019        Price: US 3300 Onwards        Pages: 132
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. The report forecast global Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Biosimilars industry and main market trends. The market research......
  • Global Biologics and Biosimilars Market Study 2016-2026, by Segment (Antibody, Hormone,) , by Market (Tumor, Diabetes,) , by Company (Roche, Amgen,)
    Published: 10-Nov-2019        Price: US 1800 Onwards        Pages: 65
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global Biosimilars Market Study 2016-2026, by Segment (Injection, Tablets,) , by Market (Ankylosing Spondylitis, Tumor,) , by Company (Sandoz International, Hospira,)
    Published: 10-Nov-2019        Price: US 1800 Onwards        Pages: 57
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. The global Biosimilars market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Injection - Tablets - Others......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs